This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Joslin Diabetes Center, Inc.. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2024
Title: Spotlight on Monika A. Niewczas: Innovating Renal Disease Diagnostics
Introduction:
Monika A. Niewczas, a talented inventor based in Boston, MA, has made significant contributions to the field of medical diagnostics. With a strong background in biomarkers, Niewczas has focused her efforts on developing methods to diagnose and predict renal disease. Let's delve into her latest patents, career highlights, and collaborations that showcase her innovative work.
Latest Patents:
Niewczas holds three patents, with her latest innovations centering around methods of diagnosing and predicting renal disease. These patents utilize a combination of biomarkers, including sTN-FR1, sTNFR2, sFAS, TNF, and IL-6, to offer more accurate and timely diagnoses for this critical health condition.
Career Highlights:
Currently affiliated with the renowned Joslin Diabetes Center, Inc., Niewczas brings her expertise to the forefront of medical research. Her work not only advances the understanding of renal disease but also paves the way for improved patient outcomes and personalized treatment approaches.
Collaborations:
In her collaborative efforts, Niewczas has teamed up with esteemed colleagues like Andrzej Krolewski. Together, they synergize their skills and knowledge to drive innovation in the healthcare industry. Krolewski, a respected figure in the field, complements Niewczas' work, further strengthening the impact of their research endeavors.
Conclusion:
Monika A. Niewczas stands as a beacon of innovation in the realm of medical diagnostics, particularly in the domain of renal disease. Her dedication to advancing healthcare through cutting-edge inventions underscores her commitment to improving the lives of patients worldwide. As Niewczas continues to pioneer new diagnostic methods, we eagerly anticipate the transformative impact of her future endeavors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
